Caplacizumab-yhdp

Placeholder slot

(KAP-luh-SIH-zoo-mab)

This page contains brief information about caplacizumab-yhdp and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Cablivi

FDA Approved

Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Caplacizumab-yhdp is approved to treat:

Acquired thrombotic thrombocytopenic purpura (aTTP) in adults. It is used with plasma exchange and immunosuppressive therapy.

More About Caplacizumab-yhdp

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trials Accepting Patients

Find Clinical Trials for Caplacizumab-yhdp - Check for trials from NCI's list of cancer clinical trials now accepting patients.